Loading...
XPARGDS
Market cap1.31bUSD
Dec 23, Last price  
11.45EUR
1D
1.33%
1Q
-21.31%
Jan 2017
-21.61%
Name

Ramsay Generale de Sante SA

Chart & Performance

D1W1MN
XPAR:GDS chart
P/E
—
P/S
0.25
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
5.41%
Rev. gr., 5y
8.04%
Revenues
5.01b
+6.49%
1,250,200,0001,435,500,0001,741,500,0001,906,000,0001,983,800,0002,046,200,0001,926,100,0001,955,000,0001,928,600,0001,869,700,0001,711,600,0002,226,900,0002,234,400,0002,241,500,0003,401,100,0003,746,200,0004,022,600,0004,301,000,0004,701,500,0005,006,500,000
Net income
-54m
L
27,400,00040,900,000225,400,00045,600,00087,200,00042,400,00037,900,000-28,500,00055,700,000111,300,00019,700,00036,900,00057,000,0007,300,00015,300,00018,700,00065,000,000118,400,00049,400,000-53,900,000
CFO
587m
-2.02%
115,300,000154,900,000152,600,000179,600,000253,300,000149,000,000194,100,000172,400,000206,700,000151,300,000159,000,000196,000,000209,400,000213,900,000213,600,000729,600,000652,300,000262,500,000598,900,000586,800,000
Dividend
Dec 02, 20140.791344 EUR/sh
Earnings
Feb 27, 2025

Profile

Ramsay Générale de Santé SA operates hospitals in France. Its hospitals offer a range of services in the areas of anesthesia, oncology, cardiology, dermatology, gastroenterology, gynecology, maternity, nephrology, neurosurgery, obesity, ophthalmology, orthopedics, stomatology, pneumonology, psychiatry, radiology, and urology, as well as thoracic, vascular, and endovascular surgeries. The company was formerly known as Générale de Santé SA and changed its name to Ramsay Générale de Santé SA in December 2015. Ramsay Générale de Santé SA was founded in 1987 and is based in Paris, France. Ramsay Générale de Santé SA operates as a subsidiary of Ramsay Health Care Limited.
URL
https://www.ramsaysante.fr/
IPO date
Jun 19, 2001
Employees
36,000
Domiciled in
FR
Incorporated in
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑062014‑12
Income
Revenues
5,006,500
6.49%
4,701,500
9.31%
4,301,000
6.92%
Cost of revenue
1,063,900
978,800
890,700
Unusual Expense (Income)
NOPBT
3,942,600
3,722,700
3,410,300
NOPBT Margin
78.75%
79.18%
79.29%
Operating Taxes
(4,100)
23,800
57,300
Tax Rate
0.64%
1.68%
NOPAT
3,946,700
3,698,900
3,353,000
Net income
(53,900)
-209.11%
49,400
-58.28%
118,400
82.15%
Dividends
Dividend yield
Proceeds from repurchase of equity
500
BB yield
Debt
Debt current
355,800
279,600
231,400
Long-term debt
5,749,000
6,009,600
5,853,100
Deferred revenue
263,700
Other long-term liabilities
259,100
3,700
289,300
Net debt
5,671,600
5,886,400
5,868,500
Cash flow
Cash from operating activities
586,800
598,900
262,500
CAPEX
(168,500)
(172,200)
(193,600)
Cash from investing activities
(180,500)
(175,400)
(471,100)
Cash from financing activities
(401,500)
(197,100)
(264,200)
FCF
4,084,900
3,669,300
3,342,500
Balance
Cash
381,300
362,900
143,500
Long term investments
51,900
39,900
72,500
Excess cash
182,875
167,725
950
Stockholders' equity
618,500
715,100
745,900
Invested Capital
5,370,025
5,522,675
5,474,050
ROIC
72.47%
67.27%
64.83%
ROCE
70.78%
64.82%
61.84%
EV
Common stock shares outstanding
110,000
110,362
110,369
Price
Market cap
EV
EBITDA
4,369,300
4,125,900
3,787,600
EV/EBITDA
Interest
199,000
154,700
114,600
Interest/NOPBT
5.05%
4.16%
3.36%